Literature DB >> 32141691

A Multidisciplinary Team Approach to the Management of Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Shuqun Cheng1, Xubiao Wei1, Jie Shi1, Weixing Guo1, Shuang Feng1, Jian Zhai1, Bin Huang1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32141691      PMCID： PMC7288629          DOI： 10.1634/theoncologist.2019-0196

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  4 in total

1.  Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?

Authors:  Yosuke Inoue; Kiyoshi Hasegawa; Takeaki Ishizawa; Taku Aoki; Keiji Sano; Yoshifumi Beck; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Surgery       Date:  2009-01       Impact factor: 3.982

2.  Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients.

Authors:  A Pawarode; N Voravud; V Sriuranpong; P Kullavanijaya; Y Z Patt
Journal:  Am J Clin Oncol       Date:  1998-08       Impact factor: 2.339

Review 3.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2016-03-05       Impact factor: 3.279

Review 4.  Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.

Authors:  Shuqun Cheng; Minshan Chen; Jianqiang Cai
Journal:  Oncotarget       Date:  2017-01-31
  4 in total
  1 in total

1.  Effect of transjugular intrahepatic portosystemic shunt combined with 125I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma.

Authors:  Hongbo Han; Yanli Meng; Jitian Wang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.